ClinicalTrials.Veeva

Menu

Comprehensive HIV and Harm Prevention Via Telehealth (CHARIOT)

University of Miami logo

University of Miami

Status

Enrolling

Conditions

HIV Infections

Treatments

Behavioral: Off-site Linkage to HIV Prevention
Behavioral: Comprehensive Tele-harm Reduction

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05897099
R01DA058352 (U.S. NIH Grant/Contract)
20230061

Details and patient eligibility

About

The purpose of this study is to test 2 different ways to offer medications to prevent human immunodeficiency virus (HIV), cure hepatitis C virus (HCV) (if applicable) and treat substance use disorder (if desired) in people who inject drugs.

Enrollment

350 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age 18 or older
  • able to speak English or Spanish
  • willing and able to sign informed consent, provide locator information and medical records release
  • non-reactive result on rapid HIV test
  • use of SSP to exchange syringes 2 times in the past 3 months
  • planning to stay in the area for 12 months

Exclusion criteria

  • reactive HIV test
  • currently on medications for opioid use disorder (MOUD) by urine drug screen
  • currently on PrEP by self-report
  • Principal or site investigator discretion
  • currently in prison or jail
  • current enrollment in Clinical Trials Network 121
  • receipt of tele-harm reduction in previous 3 months
  • signs or symptoms of acute HIV infection

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

350 participants in 2 patient groups

Comprehensive Tele-harm Reduction
Experimental group
Description:
Participants will have enhanced access to a physician and clinical psychologist via remote video technology wherever the participant is located and prefers engagement (SSP, home, shelter, encampment). Participants will be in this group for 12 months.
Treatment:
Behavioral: Comprehensive Tele-harm Reduction
Off-site Linkage to HIV prevention
Active Comparator group
Description:
Participants in this group will receive off-site linkage to HIV care by having case management/social work services through our community engagement team. Participants will be in this group for 12 months.
Treatment:
Behavioral: Off-site Linkage to HIV Prevention

Trial contacts and locations

2

Loading...

Central trial contact

Hansel Tookes, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems